Dr. Atul Kumar Nasa Honoured At DIWA Event, Named DTAB Member
Prof. (Dr.) Atul Kumar Nasa, Pro Vice Chancellor, SGT University, has been honored by the Drugs Inspectors Welfare Association (DIWA) during its Golden Jubilee Celebration for his exceptional dedication and contributions to the pharmacy profession, healthcare, and education. This recognition highlights his ongoing commitment to academic excellence, patient care, and professional leadership in the healthcare sector.
The prestigious award was presented by Shri Rajiv Singh Raghuvanshi, the Drugs Controller General of India, who attended the event as the Chief Guest. The ceremony was attended by drug regulators from across the country, along with professionals from the pharmaceutical industry and academia.
Dr. Nasa was recognized for his significant efforts in strengthening pharmaceutical education and healthcare practices in India. Over the years, his leadership and professional contributions have inspired students, healthcare professionals, and researchers nationwide.
In addition, Dr. Atul Kumar Nasa has been nominated as a member of the Drugs Technical Advisory Board (DTAB) under the Ministry of Health and Family Welfare, Government of India. DTAB is the highest statutory body advising the government on technical matters related to the safety, quality, and efficacy of drugs and cosmetics under the Drugs and Cosmetics Act of 1940.
As a renowned pharmaceutical expert and academic leader, Dr. Nasa is expected to make significant contributions to national drug policies, regulatory standards, and public health safeguards. His nomination reflects the trust placed in his expertise and leadership within the healthcare and pharmaceutical sectors.
The honor received at the DIWA Golden Jubilee Celebration marks an important milestone in his professional journey and highlights his growing influence in healthcare education, research, and policy-making at the national level.
This achievement has been widely appreciated by colleagues, students, and healthcare professionals, who have congratulated Dr. Nasa for bringing recognition to both the academic and pharmaceutical communities through his dedicated service and leadership.
